Comparing Glaxosmithkline & Barratt Developments

This page explains how Glaxosmithkline compares with Barratt Developments

In terms of market cap, Glaxosmithkline is 15.15 times greater than Barratt Developments, and each share in Glaxosmithkline is the equivalent to 3.62 shares in Barratt Developments.

  GSK   BDEV
Price 1,733.50+1,254.80478.70
Change 5.00 (0.29%)-3.7118.40 (4%)
Spread 0.50 (0.029%)-0.0130.20 (0.042%)
Currency GBX GBX
Sector Medicine and Biotech Household Goods
Indices UK All-Share, UK 350 , UK 100 UK All-Share, UK 350 , UK 100
Glaxosmithkline Intraday Chart
Barratt Developments Intraday Chart
Glaxosmithkline 3 Month Chart
Barratt Developments 3 Month Chart
What if I invested £1,000?
1 month ago 1 year ago
GSK.LN/A N/A N/A N/A N/A
BDEV.LN/A N/A N/A N/A N/A
  GSK   BDEV
Shares in Issue 4,078,024,048   974,592,261
Market Capitalisation £70,692,546,872   £4,665,373,153
52 Week High 1,739.50   582.20
52 Week Low 1,302.60   384.20